Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 1,320,000 shares, a decrease ...

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...

Baldwin Wallace defeated La Roche (Pa.) 63-53 in Friday’s first-round matchup in the NCAA Division III women's basketball ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Though David says his ankle weights warmup is “unscientific” and does not recommend this practice to the athletes he coaches, ...

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there ...

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables ...